Background COVID‐19, which is characterised by life‐threatening symptoms, difficulty in breathing, and pneumonia symptoms and requires global emergency intervention, may cause psychological problems such as phobia, fear and anxiety. This study aims to examine the psychometric properties of the Fear of COVID‐19 Scale (FCV‐19S) in Turkish people and to determine the level of fear of COVID‐19 among Turkish people. Methods The research was carried out between March and April 2020. A Personal Information Form and the FCV‐19S were used to collect the research data. In the validity and reliability stage, 84 people were contacted randomly for data collection. After the validity and reliability analyses of the scale, a total of 431 Turkish people volunteered to participate in the study and answered the questions in the online questionnaire form using a convenience and snowball sampling method. Confirmatory factor analysis, item‐total correlation and Cronbach's alpha coefficient were calculated for psychometric evaluation. Bivariate analysis was applied to determine the level of fear of COVID‐19. Results Cronbach's alpha coefficient was 0.89, which is stated to have high reliability. FCV‐19S scores of participants were determined to be 21.47 ± 6.28. FCV‐19S scores of females were determined as 20.48 ± 6.33 and FCV‐19S scores of males were determined as 19.78 ± 7.34 according to the bivariate analysis (p < .05). Age, marital status, having children and living alone or with others, tobacco use and anxiety about going to the hospital during the pandemic did not affect on fear of COVID‐19 (p > .05). Particularly being female, the presence of chronic disease requiring long‐term medication and rarely taking protective measures recommended by the Ministry of Health and having a chronic disease had a significant effect on higher levels of fear of COVID‐19 (p < .05). Conclusion The FCV‐19S is a valid and reliable tool for determining the fear of COVID‐19. It was found that the fear level of COVID‐19 infection was high in Turkish people.
17 December 2020 in TURKISH JOURNAL OF MEDICAL SCIENCES
It is claimed that aberrant immune response has a more important role than the cytopathic effect of the virus in the morbidity and mortality of the coronavirus disease 2019 (COVID-19). We aimed to investigate the possible roles of tumor necrosis factor-like weak inducer of apoptosis (TWEAK)/Fn14 pathway and leukotrienes (LT) in uncontrolled immune response that occurs in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This study included 25 asymptomatic patients and 35 patients with lung involvement who were diagnosed with COVID-19 as well as 22 healthy volunteers. Lung involvement was determined using computed-tomography. Serum TWEAK, LTE4, and prostaglandin F2α (PGF2α) levels were determined. Compared with the healthy control group, TWEAK, LTE4, and PGF2α levels were higher in the group of SARS-CoV-2 infection without lung involvement. In the group of SARS-CoV-2 infection with lung involvement, age, fibrinogen, sedimentation, C-reactive protein and ferritin, TWEAK, LTE4, and PGF2α levels were higher, and lymphocyte levels were lower compared with the asymptomatic group. In the study, TWEAK and LTE4 levels increased in cases with COVID-19. These results support that TWEAK/Fn14 pathway and LT may involved in the pathology of aberrant immune response against SARS-CoV-2. Inhibition of each of these pathways may be a potential target in the treatment of COVID-19.
14 January 2020 in Geriatrics & Gerontology International
Amaç: Bu çalışmanın amacı intramüsküler B12 replasman tedavisi ile oral B12 replasman tedavisinin kan B12 vitamini düzeyleri üzerine olan etkisinin karşılaştırılmasıdır.Materyal ve Metod: Çalışma Ankara Numune Eğitim Araştırma Hastanesi (EAH) Bilimsel Araştırmalar Değerlendirme Komisyonunun 24/07/2013 tarih ve 2013-646 sayılı kararı ile yapılmıştır. Ankara Numune EAH 3 Dahiliye polikliniğine Mayıs–Ekim 2012 tarihleri arasında başvuran ve yeni tanı B12 vitamini eksikliği saptanan, oral veya intramüsküler tedavi başlanan, bir ay sonra kontrole gelen hastalar retrospektif taranarak çalışmaya alınmıştır. İstatistiksel analizler “SPSS for Windows 20,0” paket programı ile yapılmıştır.Bulgular: Oral vitamin B12 replasman tedavisi alan 56, intramüsküler vitamin B12 replasman tedavisi alan 46 hasta bulundu. Başlangıç değerlerine göre tüm hastalarda anlamlı B12 vitamini düzey artışı olduğu görüldü. (220,73±243,47 pikogram/mililitre (pg/ml), p0,05).Sonuç: Oral ve intramüsküler B12 replasman tedavi kollarına ayrılarak yapılan bir çalışmada 90 günlük tedavi sonrasında oral ve intramüsküler tedavi ile B12 vitamini düzeyinde artış olduğu bulunmuş ancak gruplar etkinlik açısından karşılaştırılmamıştır. Bizim çalışmamızda B12 vitamini eksikliği saptanan hastalarda oral ve intramüsküler B12 replasman tedavileri arasında fark saptanmamış olması, oral replasman tedavisinin intramüsküler tedaviye alternatif olabileceğini akla getirmektedir. Konu ile ilgili yeni, daha geniş kapsamlı randomize kontrollü çalışmalara ihtiyaç olduğu ortadadır.
The aim of this study was to evaluate the effect of the flexible lightwand and ultrasonography (USG) combination on reducing the complications in percutaneous dilatational tracheostomy (PDT) opened with the forceps dilatation method. A retrospective examination was made of 138 patients between January 2014 and December 2018. Before starting to process, the anatomic structures of the patients were visualized with USG and the tracheostomy area was marked. Sedation and local anesthesia were applied to patients before the procedure, then the percutaneous tracheostomy was performed using the Griggs technique after confirmation of the tracheostomy localization defined with USG using the transillumination method with a flexible lightwand within an endotracheal tube. Complications that developed associated with the procedure were recorded. The mean age of the patients was 59.1±22.0 years and the mean length of stay in the intensive care unit was 42.3±35.5 days (range, 11-207 days). Overall, complications developed in 22 (15.6%) patients, of which 10.7% were early complications (1.4% related to the tube, 5.8% minor and 3.5% major complications). Tube- related complications were seen to develop in two patients. In the evaluation of the early minor complications, the most frequently seen complication was minor bleeding in 5.8% of the patients. No major vessel bleeding was determined in any patient in the early or late period. Of the late complications, the infection was seen to develop in four (2.8%) patients and stenosis in three (2.1%). The combination of flexible lightwand and USG in the PDT procedure minimized tube-related complications and contributed to the prevention of bleeding complications.